Francesco Ciotola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francesco Ciotola has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Harald Rittger
Klinikum Fürth, Department of Cardiology and Pneumology, Academic Teaching Hospital of the Friedrich-Alexander-University Erlangen-Nuremberg, Fürth, Germany
2 shared publications- Stylianos A. Pyxaras
Medizinische Klinik I, Klinikum Fürth, Academic Teaching Hospital of the Friedrich-Alexander-University Erlangen-Nürnberg, Jakob-Henle Str. 1, 90766 Fürth, Germany
2 shared publications - Harald Rittger
Clinic Fuerth , Fuerth , Germany
1 shared publication Stylianos Pyxaras
Klinikum Fürth, Department of Cardiology and Pneumology, Academic Teaching Hospital of the Friedrich-Alexander-University Erlangen-Nuremberg, Fürth, Germany
1 shared publication- Veronica Buia
Clinic Fuerth , Fuerth , Germany
1 shared publication
Latest Publications
- 1 January 2025
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
Kounis Syndrome Manifesting with Myocardial Infarction Due to Bi-Coronary Late Stent Thrombosis Following Anaphylaxis
A 70-year-old woman developed an anaphylactic reaction with syncope and inspiratory stridor after a wasp sting. Emergency treatment included epinephrine, cortisone, and antihistamines. Clinical Images from Journal of Invasive Cardiology. acute coronary syndrome Kounis Syndrome Stent thrombosis
- 1 January 2025
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
Kounis Syndrome Manifesting with Myocardial Infarction Due to Bi-Coronary Late Stent Thrombosis Following Anaphylaxis
A 70-year-old woman developed an anaphylactic reaction with syncope and inspiratory stridor after a wasp sting. Emergency treatment included epinephrine, cortisone, and antihistamines. Clinical Images from Journal of Invasive Cardiology. acute coronary syndrome Kounis Syndrome Stent thrombosis
- Open Access
MEMS Technology in Cardiology: Advancements and Applications in Heart Failure Management Focusing on the CardioMEMS Device
Heart failure (HF) is a complex clinical syndrome associated with significant morbidity, mortality, and healthcare costs. It is characterized by various structural and/or functional abnormalities of the heart, resulting in elevated intracardiac pressure and/or inadequate cardiac output at rest and/or during exercise. These dysfunctions can originate from a variety of conditions, including coronary artery disease, hypertension, cardiomyopathies, heart valve disorders, arrhythmias, and other lifestyle or systemic factors. Identifying the underlying cause is crucial for detecting reversible or treatable forms of HF. Recent epidemiological studies indicate that there has not been an increase in the incidence of the disease. Instead, patients seem to experience a chronic trajectory marked by frequent hospitalizations and stagnant mortality rates. Managing these patients requires a multidisciplinary approach that focuses on preventing disease progression, controlling symptoms, and preventing acute decompensations. In the outpatient setting, patient self-care plays a vital role in achieving these goals. This involves implementing necessary lifestyle changes and promptly recognizing symptoms/signs such as dyspnea, lower limb edema, or unexpected weight gain over a few days, to alert the healthcare team for evaluation of medication adjustments. Traditional methods of HF monitoring, such as symptom assessment and periodic clinic visits, may not capture subtle changes in hemodynamics. Sensor-based technologies offer a promising solution for remote monitoring of HF patients, enabling early detection of fluid overload and optimization of medical therapy. In this review, we provide an overview of the CardioMEMS device, a novel sensor-based system for pulmonary artery pressure monitoring in HF patients. We discuss the technical aspects, clinical evidence, and future directions of CardioMEMS in HF management.
Open AccessMEMS Technology in Cardiology: Advancements and Applications in Heart Failure Management Focusing on the CardioMEMS Device
Heart failure (HF) is a complex clinical syndrome associated with significant morbidity, mortality, and healthcare costs. It is characterized by various structural and/or functional abnormalities of the heart, resulting in elevated intracardiac pressure and/or inadequate cardiac output at rest and/or during exercise. These dysfunctions can originate from a variety of conditions, including coronary artery disease, hypertension, cardiomyopathies, heart valve disorders, arrhythmias, and other lifestyle or systemic factors. Identifying the underlying cause is crucial for detecting reversible or treatable forms of HF. Recent epidemiological studies indicate that there has not been an increase in the incidence of the disease. Instead, patients seem to experience a chronic trajectory marked by frequent hospitalizations and stagnant mortality rates. Managing these patients requires a multidisciplinary approach that focuses on preventing disease progression, controlling symptoms, and preventing acute decompensations. In the outpatient setting, patient self-care plays a vital role in achieving these goals. This involves implementing necessary lifestyle changes and promptly recognizing symptoms/signs such as dyspnea, lower limb edema, or unexpected weight gain over a few days, to alert the healthcare team for evaluation of medication adjustments. Traditional methods of HF monitoring, such as symptom assessment and periodic clinic visits, may not capture subtle changes in hemodynamics. Sensor-based technologies offer a promising solution for remote monitoring of HF patients, enabling early detection of fluid overload and optimization of medical therapy. In this review, we provide an overview of the CardioMEMS device, a novel sensor-based system for pulmonary artery pressure monitoring in HF patients. We discuss the technical aspects, clinical evidence, and future directions of CardioMEMS in HF management.
- 22 November 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (22) , 2792-2793
Successful Management of Iatrogenic Left Main Grade III Perforation With Coil Embolization
- 22 November 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (22) , 2792-2793
Successful Management of Iatrogenic Left Main Grade III Perforation With Coil Embolization